1-4 of 4
H. Alejandro Preti
Close
Sort by
Journal Articles

Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha

Clinical Trials & Observations
Peter McLaughlin, Elihu Estey, Armand Glassman, Jorge Romaguera, Felipe Samaniego, Ana Ayala, Kimberly Hayes, Anne Marie Maddox, H. Alejandro Preti, Fredrick B. Hagemeister
Journal: Blood
Blood (2005) 105 (12): 4573–4575.
https://doi.org/10.1182/blood-2004-08-3035
Published: 2005
Journal Articles

Myelodysplasia and Acute Myeloid Leukemia Following Therapy for Indolent Lymphoma with Fludarabine, Mitoxantrone, Dexamethasone (FND) Plus Rituximab and Interferon Alfa.

Peter McLaughlin, MD, Elihu Estey, MD, Armand Glassman, MD, Jorge Romaguera, MD, Felipe Samaniego, MD, PhD, Ana Ayala, RN, Kimberly Hayes, Anne Marie Maddox, MD, PhD, H. Alejandro Preti, MD, Fredrick B. Hagemeister, MD
Journal: Blood
Blood (2004) 104 (11): 1394.
https://doi.org/10.1182/blood.V104.11.1394.1394
Published: 2004
Journal Articles

Correlation of Bcl-2 Rearrangement With Clinical Characteristics and Outcome in Indolent Follicular Lymphoma

Armando López-Guillermo, Fernando Cabanillas, Timothy I. McDonnell, Peter McLaughlin, Terry Smith, William Pugh, Fredrick Hagemeister, M. Alma Rodrı́guez, Jorge E. Romaguera, Anas Younes, Andreas H. Sarris, H. Alejandro Preti, Ming-Seng Lee
Journal: Blood
Blood (1999) 93 (9): 3081–3087.
https://doi.org/10.1182/blood.V93.9.3081
Published: 1999
Journal Articles

The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas

Armando López-Guillermo, Fernando Cabanillas, Peter McLaughlin, Terry Smith, Fredrick Hagemeister, Marı́a A. Rodrı́guez, Jorge E. Romaguera, Anas Younes, Andreas H. Sarris, H. Alejandro Preti, William Pugh, Ming-Seng Lee
Journal: Blood
Blood (1998) 91 (8): 2955–2960.
https://doi.org/10.1182/blood.V91.8.2955.2955_2955_2960
Published: 1998